1. Home
  2. NSP vs ALVO Comparison

NSP vs ALVO Comparison

Compare NSP & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$36.21

Market Cap

1.1B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.26

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
ALVO
Founded
1986
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NSP
ALVO
Price
$36.21
$3.26
Analyst Decision
Hold
Buy
Analyst Count
3
4
Target Price
$47.67
$8.00
AVG Volume (30 Days)
581.3K
412.2K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
N/A
EPS
0.88
N/A
Revenue
$6,812,000,000.00
N/A
Revenue This Year
$3.45
$13.28
Revenue Next Year
$6.95
$18.63
P/E Ratio
$39.17
$18.20
Revenue Growth
3.51
N/A
52 Week Low
$18.57
$3.03
52 Week High
$64.49
$11.85

Technical Indicators

Market Signals
Indicator
NSP
ALVO
Relative Strength Index (RSI) 67.57 43.15
Support Level $34.14 $3.13
Resistance Level $37.70 $3.74
Average True Range (ATR) 1.86 0.16
MACD 0.41 0.00
Stochastic Oscillator 99.22 11.32

Price Performance

Historical Comparison
NSP
ALVO

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: